| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2074 | 2017 |
| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 T Sekine, A Perez-Potti, O Rivera-Ballesteros, K Strålin, JB Gorin, ... Cell 183 (1), 158-168. e14, 2020 | 1900 | 2020 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1491 | 2018 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 558 | 2014 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 411 | 2014 |
| Natural killer cell immunotypes related to COVID-19 disease severity C Maucourant, I Filipovic, A Ponzetta, S Aleman, M Cornillet, L Hertwig, ... Science immunology 5 (50), eabd6832, 2020 | 391 | 2020 |
| Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant Y Gao, C Cai, A Grifoni, TR Müller, J Niessl, A Olofsson, M Humbert, ... Nature medicine 28 (3), 472-476, 2022 | 355 | 2022 |
| Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The lancet Gastroenterology & hepatology 2 (5), 325-336, 2017 | 308 | 2017 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 303 | 2022 |
| Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication AJ van der Meer, JJ Feld, H Hofer, PL Almasio, V Calvaruso, ... Journal of hepatology 66 (3), 485-493, 2017 | 290 | 2017 |
| A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C–associated liver cirrhosis S Aleman, N Rahbin, O Weiland, L Davidsdottir, M Hedenstierna, N Rose, ... Clinical Infectious Diseases 57 (2), 230-236, 2013 | 286 | 2013 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 272 | 2014 |
| Association of aspirin with hepatocellular carcinoma and liver-related mortality TG Simon, AS Duberg, S Aleman, RT Chung, AT Chan, JF Ludvigsson New England Journal of Medicine 382 (11), 1018-1028, 2020 | 252 | 2020 |
| Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial P Bergman, O Blennow, L Hansson, S Mielke, P Nowak, P Chen, ... EBioMedicine 74, 2021 | 195 | 2021 |
| MAIT cell activation and dynamics associated with COVID-19 disease severity T Parrot, JB Gorin, A Ponzetta, KT Maleki, T Kammann, J Emgård, ... Science immunology 5 (51), eabe1670, 2020 | 178 | 2020 |
| Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy S Aleman, K Söderbärg, U Visco-Comandini, G Sitbon, A Sönnerborg Aids 16 (7), 1039-1044, 2002 | 134 | 2002 |
| Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity E Kvedaraite, L Hertwig, I Sinha, A Ponzetta, I Hed Myrberg, M Lourda, ... Proceedings of the National Academy of Sciences 118 (6), e2018587118, 2021 | 126 | 2021 |
| Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population TG Simon, AS Duberg, S Aleman, H Hagstrom, LH Nguyen, H Khalili, ... Annals of internal medicine 171 (5), 318-327, 2019 | 117 | 2019 |
| Tissue‐resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL‐17 MJ Sobkowiak, H Davanian, R Heymann, A Gibbs, J Emgård, J Dias, ... European journal of immunology 49 (1), 133-143, 2019 | 104 | 2019 |
